CAS No.:104344-23-2
Name: Bisoprolol fumarate
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LDLo | oral | 40mg/kg (40mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2321, 1989. |
| mouse | LD50 | intravenous | 111mg/kg (111mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2313, 1989. |
| mouse | LD50 | oral | 678mg/kg (678mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2313, 1989. |
| rat | LD50 | intravenous | 39mg/kg (39mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2313, 1989. |
| rat | LD50 | oral | 940mg/kg (940mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2313, 1989. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes:
Xn,
Xi
Risk Statements: 22
R22:Harmful if swallowed.
WGK Germany: 3
RTECS: UB8390000
Beta-blockers can precipitate asthma and this effect can be dangerous. Beta-blockers should be avoided in patients with a history of asthma or bronchospasm; if there is no alternative, a cardioselective beta-blocker can be used with extreme caution under specialist supervision. atenolol, bisoprolol, METOPROLOL, nebivolol, and (to a lesser extent) ACEBUTOLOL, have less effect on the beta2 (bronchial) receptors and are, therefore, relatively cardioselective, but they are not cardiospecific. They have a lesser effect on airways resistance but are not free of this side-effect.
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Jai Radhe Sales
- LIDE PHARMACEUTICALS LIMITED
- Afine Chemicals Limited
- Dayang Chem (Hangzhou) Co.,Ltd.
- Jinan Finer Chemical Co., Ltd
- BOC Sciences
- Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
- Logikem Limited
- Suzhou Howsine Biological Technology Co.,Ltd(expird)
- ADVANCED TECH. & IND. CO., LTD.
- VESINO INDUSTRIAL CO., LTD.
- Harman Finochem Ltd.
- Shanghai chemrole co.,ltd
- Beijing Mediking Biopharm Co., Ltd.
- Unachem Trading Co., Ltd.
- Hangzhou Pharma & Chem Co.,Ltd.
- Jiangxi Biochem Co.,Ltd
- Huaian Synniken Chemical Co.,Ltd.
- Gencor Pacific Inc.
- Gyma Laboratories Of America, Inc.
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione

